跳至主要内容
临床试验/NCT02925351
NCT02925351已完成早期 1 期

The Biodistribution of 18F-Clofarabine in Patients With Autoimmune and Inflammatory Diseases

Jonsson Comprehensive Cancer Center2 个研究点 分布在 1 个国家目标入组 8 人开始时间: 2016年1月25日最近更新:
适应症

试验速览

阶段
早期 1 期
状态
已完成
入组人数
8
试验地点
2
主要终点
Standardized Uptake Value

研究概览

简要总结

This pilot trial studies how well fluorine F 18 clofarabine positron emission tomography (PET)/computed tomography (CT) works in imaging patients with autoimmune or inflammatory diseases. Fluorine F 18 clofarabine is an imaging agent or tracer which may be taken up by inflammatory tissue in the body. Diagnostic imaging, such as PET/CT scans, can be used to measure the amount of injected tracer that is taken up by inflammatory tissue. PET/CT scan may help to determine how fluorine F 18 clofarabine is distributed throughout the body.

详细描述

PRIMARY OBJECTIVES:

I. Determine how fluorine F 18 clofarabine (18F-clofarabine) is distributed in the body, in patients with autoimmune and inflammatory diseases.

II. Determine whether 18F-clofarabine can be used to image patients with autoimmune and inflammatory diseases.

OUTLINE:

Patients receive fluorine F 18 clofarabine intravenously (IV) and undergo a single PET/CT scan for up to 120 minutes.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Must be 18 years or older.
  • Diagnosed with an autoimmune and inflammatory disorder.
  • Exclusion Criteria
  • Women of childbearing age will have to undergo a pregnancy test that will be provided free of charge.
  • Patients unable to undergo or comply with PET/CT scanning due to pre-existing medical conditions including claustrophobia.

排除标准

  • 未提供

结局指标

主要结局

Standardized Uptake Value

时间窗: Baseline up to 240 minutes after injection

Standardized Uptake Value (SUV) will be the primary unit for assessment. Using standard PET/CT viewing software, the SUV will be measured for different organs and lesions of suspected disease and compared to reference/background tissues.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验